Shortage of key medicines poses risk to patients’ health
Newly elected IPU president Rory O’Donnell has called on the Department of Health to ensure that an adequate supply of vital medicines is constantly available to minimised the threat to the safety of patients.
Mr O’Donnell said: “This has been happening for years. The latest example is the shortage of Eltroxin, a drug used to treat thyroid problems, a common disorder. It is not acceptable in this day and age that the health of some patients is compromised due to a shortage of medicines.”
